Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted proteomics improves cardiovascular risk prediction in secondary prevention.
Nurmohamed NS, Belo Pereira JP, Hoogeveen RM, Kroon J, Kraaijenhof JM, Waissi F, Timmerman N, Bom MJ, Hoefer IE, Knaapen P, Catapano AL, Koenig W, de Kleijn D, Visseren FLJ, Levin E, Stroes ESG. Nurmohamed NS, et al. Among authors: stroes esg. Eur Heart J. 2022 Apr 19;43(16):1569-1577. doi: 10.1093/eurheartj/ehac055. Eur Heart J. 2022. PMID: 35139537 Free PMC article.
Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.
Vergeer M, Bots ML, van Leuven SI, Basart DC, Sijbrands EJ, Evans GW, Grobbee DE, Visseren FL, Stalenhoef AF, Stroes ES, Kastelein JJ. Vergeer M, et al. Circulation. 2008 Dec 9;118(24):2515-22. doi: 10.1161/CIRCULATIONAHA.108.772665. Epub 2008 Nov 24. Circulation. 2008. PMID: 19029469 Clinical Trial.
Lipid measures and cardiovascular disease prediction.
van Wijk DF, Stroes ES, Kastelein JJ. van Wijk DF, et al. Dis Markers. 2009;26(5-6):209-16. doi: 10.3233/DMA-2009-0636. Dis Markers. 2009. PMID: 19773610 Free PMC article. Review.
C-reactive protein is a mediator of cardiovascular disease.
Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ. Bisoendial RJ, et al. Eur Heart J. 2010 Sep;31(17):2087-91. doi: 10.1093/eurheartj/ehq238. Epub 2010 Aug 3. Eur Heart J. 2010. PMID: 20685682 Review.
Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial.
Visser ME, Wagener G, Baker BF, Geary RS, Donovan JM, Beuers UH, Nederveen AJ, Verheij J, Trip MD, Basart DC, Kastelein JJ, Stroes ES. Visser ME, et al. Eur Heart J. 2012 May;33(9):1142-9. doi: 10.1093/eurheartj/ehs023. Epub 2012 Apr 16. Eur Heart J. 2012. PMID: 22507979 Free PMC article. Clinical Trial.
460 results